370 related articles for article (PubMed ID: 34936112)
1. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
Pourgholaminejad A; Pahlavanneshan S; Basiri M
Scand J Immunol; 2022 Feb; 95(2):e13131. PubMed ID: 34936112
[TBL] [Abstract][Full Text] [Related]
2. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?
Bellgrau D; Modiano JF
Scand J Immunol; 2021 Mar; 93(3):e12979. PubMed ID: 32991014
[No Abstract] [Full Text] [Related]
3. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells.
Wang L; Li Y; Xu M; Deng Z; Zhao Y; Yang M; Liu Y; Yuan R; Sun Y; Zhang H; Wang H; Qian Z; Kang H
Front Immunol; 2021; 12():726909. PubMed ID: 34394132
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
[TBL] [Abstract][Full Text] [Related]
6. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19.
Gu J; Zhao Q; Han Z; Han Z
Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428
[TBL] [Abstract][Full Text] [Related]
7. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
Cheng X; Jiang M; Long L; Meng J
Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
[No Abstract] [Full Text] [Related]
8. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
Pinheiro MM; Fabbri A; Infante M
Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
[TBL] [Abstract][Full Text] [Related]
9. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
Front Immunol; 2021; 12():738697. PubMed ID: 34659231
[TBL] [Abstract][Full Text] [Related]
10. The Role of Th17 Response in COVID-19.
Martonik D; Parfieniuk-Kowerda A; Rogalska M; Flisiak R
Cells; 2021 Jun; 10(6):. PubMed ID: 34205262
[TBL] [Abstract][Full Text] [Related]
11. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
12. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
Gurunathan S; Kang MH; Kim JH
Front Immunol; 2021; 12():716407. PubMed ID: 34394121
[TBL] [Abstract][Full Text] [Related]
13. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19.
Cai Q; Yin F; Hao L; Jiang W
Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385
[TBL] [Abstract][Full Text] [Related]
14. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
Jamshidi E; Babajani A; Soltani P; Niknejad H
Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
[TBL] [Abstract][Full Text] [Related]
15. The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19.
Li X; Yan M; Chen J; Luo Y
Biomed Res Int; 2021; 2021():3178796. PubMed ID: 34840969
[TBL] [Abstract][Full Text] [Related]
16. The role of CD4
Wang Y; Zheng J; Islam MS; Yang Y; Hu Y; Chen X
Int J Biol Sci; 2021; 17(6):1507-1520. PubMed ID: 33907514
[TBL] [Abstract][Full Text] [Related]
17. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
Darif D; Hammi I; Kihel A; El Idrissi Saik I; Guessous F; Akarid K
Microb Pathog; 2021 Apr; 153():104799. PubMed ID: 33609650
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.
Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA
Cells; 2022 Jul; 11(14):. PubMed ID: 35883618
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
Front Immunol; 2021; 12():589095. PubMed ID: 33995341
[TBL] [Abstract][Full Text] [Related]
20. Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment.
Balaji Easwaran V; Satarker S; V Gujaran T; John J; Veedu AP; George KT; Purayil DK; Beegum F; Mathew A; Vibhavari R; Chaudhari SS; Pai KSR
Curr Stem Cell Res Ther; 2023; 18(5):653-675. PubMed ID: 36424799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]